Drug holiday utilisation in ADHD-diagnosed children and adolescents in South Africa.
OBJECTIVE
Attention deficit hyperactivity disorder (ADHD) is a prevalent disorder affecting people in all age groups. Pharmacological treatment with psychostimulants, specifically methylphenidate, is first line management. The ideal dosing regimen of methylphenidate is debatable with daily use being considered harmful by many. However, it is unknown if sporadic drug withdrawal is beneficial to management. The primary aim was to investigate drug holiday utilisation incidence.


METHODS
The study comprised a drug utilisation review (DUR) and questionnaire-based survey. The DUR was conducted using a corporate retail pharmacy group database. Methylphenidate prescriptions were evaluated to determine possible drug holiday use through different analyses of dispensing patterns. The survey included several questions relating to drug holiday use.


RESULTS
Drug holiday use was identified in both study populations. Weekends and school holidays were identified as common periods for drug holiday observation. Of the participants that provided reasons for drug holiday utilisation, half indicated that methylphenidate was only necessary for school activities. DUR results indicated that drug holidays appeared to be more commonly observed during March and December.


CONCLUSIONS
Reasons for drug holiday utilisation were variable. This study recommends that these drug free periods are only observed if shown to be beneficial to the patient.
a Department of Pharmacy , Nelson Mandela Metropolitan University , PO Box 77000, Port Elizabeth 6031 , South Africa.
Judith
J
Regnart
Jane
J
McCartney
Ilse
I
Truter
D000293:Adolescent; D001289:Attention Deficit Disorder with Hyperactivity / Q000188:drug therapy*; D000697:Central Nervous System Stimulants / Q000627:therapeutic use*; D002648:Child; D004334:Drug Administration Schedule; D011307:Drug Prescriptions / Q000706:statistics & numerical data; D017723:Drug Utilization Review; D005260:Female; D006801:Humans; D008297:Male; D008774:Methylphenidate / Q000627:therapeutic use*; D013019:South Africa; D011795:Surveys and Questionnaires; D013997:Time Factors; D028761:Withholding Treatment; D016903:Drug Monitoring
D000697:Central Nervous System Stimulants; D008774:Methylphenidate